vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and DHT Holdings, Inc. (DHT). Click either name above to swap in a different company.

DHT Holdings, Inc. is the larger business by last-quarter revenue ($107.3M vs $77.6M, roughly 1.4× Bioceres Crop Solutions Corp.). DHT Holdings, Inc. runs the higher net margin — 41.7% vs -9.6%, a 51.3% gap on every dollar of revenue. On growth, Bioceres Crop Solutions Corp. posted the faster year-over-year revenue change (-16.8% vs -24.5%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

DHT Holdings, Inc. is an independent international crude oil tanker operator that owns and manages a fleet of very large crude carriers. It offers marine transportation services for crude oil across major global trade routes, serving clients including leading oil producers, refineries, and commodity trading enterprises worldwide.

BIOX vs DHT — Head-to-Head

Bigger by revenue
DHT
DHT
1.4× larger
DHT
$107.3M
$77.6M
BIOX
Growing faster (revenue YoY)
BIOX
BIOX
+7.6% gap
BIOX
-16.8%
-24.5%
DHT
Higher net margin
DHT
DHT
51.3% more per $
DHT
41.7%
-9.6%
BIOX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BIOX
BIOX
DHT
DHT
Revenue
$77.6M
$107.3M
Net Profit
$-7.4M
$44.8M
Gross Margin
46.8%
Operating Margin
9.3%
44.2%
Net Margin
-9.6%
41.7%
Revenue YoY
-16.8%
-24.5%
Net Profit YoY
-20.2%
27.3%
EPS (diluted)
$-0.12
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
DHT
DHT
Q3 25
$77.6M
$107.3M
Q1 25
$60.6M
Q4 24
$98.8M
Q3 24
$93.3M
$142.1M
Q1 24
$84.0M
Q4 23
$140.2M
Q3 23
$116.6M
$131.6M
Q1 23
$92.5M
Net Profit
BIOX
BIOX
DHT
DHT
Q3 25
$-7.4M
$44.8M
Q1 25
$-1.6M
Q4 24
$605.2K
Q3 24
$-6.2M
$35.2M
Q1 24
$9.8M
Q4 23
$1.2M
Q3 23
$-2.7M
$31.0M
Q1 23
$27.5M
Gross Margin
BIOX
BIOX
DHT
DHT
Q3 25
46.8%
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q1 24
50.8%
Q4 23
36.7%
Q3 23
38.6%
Q1 23
62.1%
Operating Margin
BIOX
BIOX
DHT
DHT
Q3 25
9.3%
44.2%
Q1 25
1.5%
Q4 24
14.5%
Q3 24
2.5%
29.7%
Q1 24
15.7%
Q4 23
12.0%
Q3 23
4.5%
29.7%
Q1 23
32.3%
Net Margin
BIOX
BIOX
DHT
DHT
Q3 25
-9.6%
41.7%
Q1 25
-2.6%
Q4 24
0.6%
Q3 24
-6.6%
24.8%
Q1 24
11.6%
Q4 23
0.9%
Q3 23
-2.3%
23.5%
Q1 23
29.7%
EPS (diluted)
BIOX
BIOX
DHT
DHT
Q3 25
$-0.12
$0.28
Q1 25
$-0.02
Q4 24
$0.00
Q3 24
$-0.10
$0.22
Q1 24
$0.14
Q4 23
$0.00
Q3 23
$-0.07
$0.19
Q1 23
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
DHT
DHT
Cash + ST InvestmentsLiquidity on hand
$15.5M
$81.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$1.1B
Total Assets
$734.9M
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
DHT
DHT
Q3 25
$15.5M
$81.3M
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
$73.8M
Q1 24
$16.4M
Q4 23
$24.4M
Q3 23
$28.4M
$73.9M
Q1 23
$57.7M
Stockholders' Equity
BIOX
BIOX
DHT
DHT
Q3 25
$288.3M
$1.1B
Q1 25
$345.0M
Q4 24
$346.3M
Q3 24
$346.0M
$1.0B
Q1 24
$348.5M
Q4 23
$335.3M
Q3 23
$332.6M
$1.0B
Q1 23
$334.3M
Total Assets
BIOX
BIOX
DHT
DHT
Q3 25
$734.9M
$1.4B
Q1 25
$798.2M
Q4 24
$835.2M
Q3 24
$827.3M
$1.5B
Q1 24
$836.1M
Q4 23
$819.5M
Q3 23
$819.7M
$1.5B
Q1 23
$846.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
DHT
DHT
Operating Cash FlowLast quarter
$14.4M
$60.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
DHT
DHT
Q3 25
$14.4M
$60.9M
Q1 25
$23.3M
Q4 24
$-5.4M
Q3 24
$5.2M
$80.1M
Q1 24
$-17.4M
Q4 23
$21.1M
Q3 23
$14.7M
$55.7M
Q1 23
$2.2M
Cash Conversion
BIOX
BIOX
DHT
DHT
Q3 25
1.36×
Q1 25
Q4 24
-8.85×
Q3 24
2.28×
Q1 24
-1.78×
Q4 23
17.05×
Q3 23
1.80×
Q1 23
0.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons